Cardiac pacemaking: an obligatory role of catecholamines?
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport; D002118:Calcium / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism / Q000502:physiology*; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D005089:Exocytosis; D006321:Heart / Q000196:embryology; D006339:Heart Rate / Q000187:drug effects; D008465:Mechanoreceptors / Q000502:physiology; D008564:Membrane Potentials; D008781:Methyltyrosines / Q000494:pharmacology; D008954:Models, Biological; D009200:Myocardial Contraction / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D012508:Sarcolemma / Q000378:metabolism; D012849:Sinoatrial Node / Q000201:enzymology / Q000294:innervation / Q000502:physiology* / Q000648:ultrastructure
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D008781:Methyltyrosines; D012110:Reserpine; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D006152:Cyclic GMP; D002118:Calcium